Bortezomib, Doxorubicin and Dexamethasone in Advanced Multiple Myeloma-

http://www.medscape.com/v...

 The reason I posted this study is first that this is another possible drug combination for those mmers who are refractory and second, that the study cites the synergies of bortazimb when combined with other chemos-

"Clinical trials employing bortezomib in combination with other agents
have shown additive or synergistic activity. Partial response (PR)
rates have ranged from 27% to 50% in relapsed/refractory MM.^[2,6-8]
The combination of bortezomib and pegylated liposomal doxorubicin (PLD)
in patients with advanced disease has further increased the PR rate up
to 48%–73%..."

David